TXNDC17抗体—艾普蒂

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P08927(TXNDC17 Antibody) at dilution 1/300. (Original magnification: ×200)    

  
  

The TXNDC17 (Thioredoxin Domain-Containing Protein 17) antibody is a tool used to study the function and expression of the TXNDC17 protein, a member of the thioredoxin family. Thioredoxins are small redox-active proteins involved in antioxidant defense, redox signaling, and regulation of cellular processes. TXNDC17 contains a conserved thioredoxin-like domain, suggesting roles in maintaining redox homeostasis by catalyzing disulfide bond reduction or isomerization. It is implicated in cellular stress responses, apoptosis, and mitochondrial function, though its precise biological mechanisms remain less characterized compared to other thioredoxin family members.

Research using TXNDC17 antibodies has helped identify its subcellular localization, primarily in mitochondria, and its interaction with proteins involved in oxidative phosphorylation and energy metabolism. Studies suggest its potential involvement in diseases linked to oxidative stress, such as cancer and neurodegenerative disorders. Antibodies against TXNDC17 are typically developed in rabbits or mice, using immunogenic peptide sequences or recombinant proteins. They are widely utilized in techniques like Western blotting, immunohistochemistry, and immunofluorescence to assess TXNDC17 expression patterns in tissues or cell lines. Recent investigations also explore its role as a biomarker or therapeutic target, emphasizing its importance in redox biology and disease pathology.